the COVID-19 drug remdesivir. Gilead is now going on the offensive in Europe. The European Patent Office recently granted EP 3 854 403. The patent belongs to the Academy of Military Medical Sciences
in line for a Chinese patent for its drug called Remdesivir, which shows promise against the broad family of coronaviruses. But now a team of Chinese scientists say they’ve improved and targeted its
total 1 pages, 2 items